Sahajanand Medical Technologies (SMT), a manufacturer of cardiac stents, on Wednesday said it has raised Rs230 crore in a funding round led by Morgan Stanley Private Equity Asia. — Mint

Economic Laws Practice (ELP) advised previous investor Samara Capital, which also joined the round, led by a team of partner Darshan Upadhyay, associate partner Shyam Pandya, associate partner Ananthram Ganesh, associate manager Alysha Razvi.

Shardul Amarchand Mangaldas acted for Sahajanand Medical Technologies Private Limited.

Trilegal acted for Morgan Stanley Private Equity Asia.

2018-01-02

Deal value: USD 35.21 Million

{incomplete}